Project Grant RF1AG093527
Award Date 9/30/25
Completion Date 9/29/29
Dollars Obligated $3M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Tucson, AZ 85721, USA
Similar Awards
- This federal Project Grant award of $307,000.00 from the National Institute on Aging (CFDA 93.866 - Aging Research) aims to conduct a single, highly powered study to identify memory processes that are most sensitive to the asymptomatic, preclinical stage of Alzheimer's disease (AD) pathology. The study combines a continuous report item-location associative memory task with advanced behavioral and neural modeling to estimate subtle changes in memory precision that may differentiate healthy...
- This federal Project Grant award of $2,631,670 from the National Institute on Aging (CFDA 93.866 Aging Research) supports a research initiative at The Washington University to investigate age-related deficits in episodic memory. The project aims to determine how aging distinctly affects the content and structure of memory representations, and how this relates to dysfunction in different brain networks based on susceptibility to Alzheimer's disease pathology. The research will utilize plasma...
- The National Institute on Aging, under the Aging Research Federal Grant Program (CFDA 93.866), awarded a $162,486 project grant to The Research Foundation for the State University of New York (Upstate Medical Center). The grant, titled "Advancing Alzheimer's Diagnosis: MRI-Based Predictive Modeling of Alzheimer's Disease Molecular Subtypes", aims to enhance understanding of the biological signatures that distinguish subgroups of Alzheimer's disease (AD) patients. The research will...
- The National Institute on Aging (NIA), under the Aging Research federal grant program (CFDA 93.866), awarded a $2,465,320 project grant to Arizona State University (ASU) to develop a performance-based measure of daily function for screening Hispanic/Latino older adults for Alzheimer's disease (AD) risk. The award period spans from Sep 15, 2025 to Sep 14, 2029. The goal is to leverage the existing MindCrowd electronic cohort to evaluate a newly developed, brief, and simple behavioral test (the...
- The National Institute on Aging (NIA), under the Aging Research Federal Grant Program (CFDA 93.866), awarded a $770,558 project grant to Wake Forest University Health Sciences (WFUHS) to establish connections between Alzheimer's disease (AD)-related genomic markers and neuroimaging phenotypes. The objective is to determine the heterogeneity of AD subtypes and their association with the clinical onset of dementia. The project aims to develop data-driven computational models using multi-modal...
- The National Institute on Aging (NIA), part of the Department of Health and Human Services National Institutes of Health, awarded a $3.37 million Project Grant to The University of Texas at Arlington to develop an individualized deep connectome framework for Alzheimer's disease and related dementias (ADRD) analysis. The three-year grant, awarded on August 18, 2022 under the NIA's Aging Research program (CFDA 93.866), will support research to discover and identify individualized...
- This Project Grant award for $301,417 was provided by the National Institute on Aging (NIA) under the Aging Research federal grant program (CFDA 93.866) to the University of Arizona. The award aims to develop innovative methods and tools for integrating data from Alzheimer's disease and related dementias (AD/ADRD) studies to address challenges posed by inconsistencies among evidence from different studies, particularly for comparative effectiveness research. The project has two main...
- The National Institute on Aging (NIA), under the Federal Aging Research program (CFDA 93.866), awarded a $245,148 project grant to Eyenexo LLC to develop an automated rodent behavior testing system for non-invasively assessing early-stage Alzheimer's disease (AD). The project aims to develop a behavior biomarker that can differentiate AD from normal aging by studying defensive behaviors triggered by looming stimuli, which are linked to early AD pathology in the midbrain region. The 2-year...
- This federal Project Grant award of $3,221,450.00 from the National Institute on Aging (CFDA 93.866 Aging Research) supports research to define how neuronal hyperexcitability in the retrosplenial cortex (RSC) contributes to the development of Alzheimer's disease (AD)-related behavioral deficits in mouse models. The research aims to determine the effect of inhibiting RSC layer 5 cells on spatial memory and navigation, as well as when hyperexcitability emerges in these cells across different AD...
- This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will fund research at the University of California, San Diego (UCSD) to investigate the underlying cognitive mechanisms that drive the sensitivity of autocorrection errors in connected speech to early-stage Alzheimer's disease (AD). The $294,484 award will support a 2-year study that combines behavioral and eye-tracking measures to test attention, monitoring, and syntactic constraint accounts for...